Russian drug from COVID-19 will represent the countries of Latin America

The Russian Embassy in Guatemala, together with the Russian direct investment Fund (RDIF) on 10 July, will hold a presentation of the drug against the coronavirus, "Aviewer" for Latin America and the Caribbean, it has already signed up about 800 people, reported RIA of news in Embassy.

"The development of the theme of the fight against coronavirus Embassy jointly with the company "Kramis", "Khimrar" and the FUND, vyvedshie on the Russian market the drug against the coronavirus, "Aviewer", organizes his presentation in Latin America and the Caribbean. To participate in the conference invited representatives of all supranational parliaments of the region, relevant agencies and committees," said the Embassy.

"According to our data, at the moment signed up about 800 people. Expected increased representation of countries such as Chile, Colombia and Bolivia and the Central American Parliament, Parliament of the Andean community, Latin American Parliament, the MERCOSUR Parliament", - said the representative of the Embassy.

The Embassy said it had no information about any official request from the Serbian authorities regarding the acquisition of Russian drug. "However, we believe that after the video conference can begin negotiations for the supply of "Avifauna" in Latin America and the Caribbean," added the Embassy.

"Aviewer" may 29, received a registration certificate of Ministry of health of the Russian Federation and became the world's first drug against the coronavirus that contains the active substance "Favipiravir", and on 3 June was included in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection. RDIF has asked the health Ministry to allow the use of "Avifauna" outpatient those treated for the coronavirus of the house.

The Ministry of industry and trade of the Russian Federation previously received applications for the supply of "Avifauna" from the CIS countries, Latin America, Europe and Southeast Asia.

Relevant data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.